Form D · Other Health Care
ivWatch LLC
Newport News, VA · CIK 0001511754
Offering snapshot reported Sep 19, 2024 · SEC filing
- Reported sold
- $26.9M Offering amount: $33.3M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 12, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$22,958,659 → $26,933,659
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 19, 2024 | Amendment | $26,933,659 | $3,975,000vs Jun 14, 2024 | 16 | SEC filing |
| Jun 14, 2024 | Amendment | $22,958,659 | $8,568,191vs Jan 26, 2024 | 16 | SEC filing |
| Jan 26, 2024 | Initial | $14,390,468 | No comparison | 6 | SEC filing |
| Jan 9, 2024 | Amendment | $17,452,641 | $6,759,680vs May 4, 2023 | 21 | SEC filing |
| May 4, 2023 | Initial | $10,692,961 | No comparison | 9 | SEC filing |
| Feb 10, 2022 | Amendment | $13,709,845 | $3,233,310vs Nov 1, 2021 | 15 | SEC filing |
| Nov 1, 2021 | Amendment | $10,476,535 | $8,976,535vs Jul 7, 2020 | 14 | SEC filing |
| Jul 7, 2020 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Jan 3, 2020 | Amendment | $18,918,445 | $6,550,000vs Mar 14, 2019 | 51 | SEC filing |
| Mar 14, 2019 | Amendment | $12,368,445 | $10,368,445vs Oct 10, 2017 | 47 | SEC filing |
| Oct 10, 2017 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Mar 7, 2017 | Amendment | $12,772,362 | $3,483,213vs Jan 6, 2017 | 74 | SEC filing |
| Jan 6, 2017 | Amendment | $9,289,149 | $7,182,227vs Sep 18, 2015 | 49 | SEC filing |
| Sep 18, 2015 | Initial | $2,106,922 | No comparison | 7 | SEC filing |
| Apr 2, 2014 | Initial | $668,746 | No comparison | 8 | SEC filing |
| Apr 16, 2013 | Amendment | $2,835,003 | $1,648,003vs Nov 21, 2012 | 24 | SEC filing |
| Nov 21, 2012 | Initial | $1,187,000 | No comparison | 9 | SEC filing |
| Dec 22, 2011 | Amendment | $2,725,000 | $2,625,000vs Feb 2, 2011 | 19 | SEC filing |
| Feb 2, 2011 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503531
Of the amount sold thus far, $16,283,659 represents the aggregate principal amount of certain prior convertible notes exchanged for new convertible notes in this offering.
Source: Form D, filed Sep 19, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Alley | Executive |
| Scott Anchell | Executive |
| Teresa Blevins | Executive |
| Garret Bonnema | Executive |
| Marilyn Bowers | Executive |
| Susan Brown | Executive |
| Kathleen Carter | Executive |
| Nee Yin Chou | Director, Executive |
| F. Brian Clare | Director, Executive |
| F. Brian Clare Jr. | Director, Executive |
| Anne Conner | Director |
| Kathleen Cox | Executive |
| Chuck Egress | Executive |
| Melissa Fire | Executive |
| Michael C. Gahan | Director, Executive |
| John Gahan | Executive |
| John R. Gahan Jr. | Executive |
| Javier Garriz | Executive |
| Scott Hensley | Executive |
| Jaclyn Lautz | Director, Executive |
| John R. Lawson | Director |
| John R. Lawson Ii | Director |
| Nicole T. Lowe | Executive |
| Jerrold L. Miller | Director |
| Leah Moore | Executive |
| William Jason Naramore | Executive |
| Holly Novak | Executive |
| Michael N. Petkovich | Director |
| Christopher Pridgen | Executive |
| Gregory Schears | Executive |
| Helen Stephens | Executive |
| Paul Stoddard | Executive |
| Gary P. Warren | Director, Executive |
| Erin Wendell | Executive |
| Leonard W. Winchester | Director |
| John O. Wynne | Director |
| John O. Wynne Jr. | Director |
| John Zwirschitz | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
700 Tech Center Parkway Suite 300
Newport News, VA, 23606
Newport News, VA, 23606